Literature DB >> 17100629

Immunomodulating effects of flavonoids on acute and chronic inflammatory responses caused by tumor necrosis factor alpha.

Yoshio Kumazawa1, Kiichiro Kawaguchi, Hiroaki Takimoto.   

Abstract

Flavonoids have beneficial activities which modulate oxidative stress, allergy, tumor growth and viral infection, and which stimulate apoptosis of tumor cells. In addition to these activities, dietary flavonoids are able to regulate acute and chronic inflammatory responses. Here we describe new aspects of regulatory mechanisms by which flavonoids suppress production of tumor necrosis factor-alpha (TNF-alpha) by macrophages, microglial cells and mast cells stimulated with lipopolysaccharide (LPS) and others via toll-like receptors (TLRs), and TNF-alpha-mediated acute and chronic inflammatory responses. Treatment with flavonoids such as luteolin, apigenin, quercetin, genistein, (-)-epigallocatechin gallate, and anthocyanidin resulted in significant downregulation of LPS-elicited TNF-alpha and nitric oxide (NO) production and diminished lethal shock. In chronic diseases, pathogenesis of collagen-induced arthritis (CIA), a mouse model of rheumatoid arthritis which is triggered by TNF-alpha, was improved by the oral administration of flavonoids after the onset of CIA. Here, we discuss that inhibitory effects of flavonoids on acute and chronic inflammation are due to regulation of signaling pathways, including the nuclear factor kappaB (NF-kappaB) activation and mitogen-activated protein (MAP) kinase family phosphorylation. FcetaRI expression by NF-kappaB activation was also reduced by flavonoids; while accumulation of lipid rafts, which is the critical step for signaling, was blocked by flavonoids. The intake of dietary flavonoids reduces acute and chronic inflammation due to blocking receptor accumulation and signaling cascades, and would assist individuals at high-risk from life-style related diseases.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17100629     DOI: 10.2174/138161206778743565

Source DB:  PubMed          Journal:  Curr Pharm Des        ISSN: 1381-6128            Impact factor:   3.116


  32 in total

1.  Quercetin inhibits IL-1β-induced proliferation and production of MMPs, COX-2, and PGE2 by rheumatoid synovial fibroblast.

Authors:  Myung-Soon Sung; Eun-Gyeong Lee; Hyun-Soon Jeon; Han-Jung Chae; Seoung Ju Park; Yong Chul Lee; Wan-Hee Yoo
Journal:  Inflammation       Date:  2012-08       Impact factor: 4.092

2.  Pretreatment with quercetin prevents changes in lymphocytes E-NTPDase/E-ADA activities and cytokines secretion in hyperlipidemic rats.

Authors:  Josiane B S Braun; Jader B Ruchel; Alessandra G Manzoni; Fátima H Abdalla; Emerson A Casalli; Lívia G Castilhos; Daniela F Passos; Daniela B R Leal
Journal:  Mol Cell Biochem       Date:  2017-11-29       Impact factor: 3.396

3.  Luteolin inhibits myelin basic protein-induced human mast cell activation and mast cell-dependent stimulation of Jurkat T cells.

Authors:  D Kempuraj; M Tagen; B P Iliopoulou; A Clemons; M Vasiadi; W Boucher; M House; A Wolfberg; T C Theoharides
Journal:  Br J Pharmacol       Date:  2008-09-22       Impact factor: 8.739

4.  The effects of morin on lipopolysaccharide-induced acute lung injury by suppressing the lung NLRP3 inflammasome.

Authors:  Zhang Tianzhu; Yang Shihai; Du Juan
Journal:  Inflammation       Date:  2014-12       Impact factor: 4.092

Review 5.  Effects of supplementation with quercetin on plasma C-reactive protein concentrations: a systematic review and meta-analysis of randomized controlled trials.

Authors:  M Mohammadi-Sartang; Z Mazloom; S Sherafatmanesh; M Ghorbani; Donya Firoozi
Journal:  Eur J Clin Nutr       Date:  2017-05-24       Impact factor: 4.016

6.  Black currant anthocyanins normalized abnormal levels of serum concentrations of endothelin-1 in patients with glaucoma.

Authors:  Kaori Yoshida; Ikuyo Ohguro; Hiroshi Ohguro
Journal:  J Ocul Pharmacol Ther       Date:  2012-12-21       Impact factor: 2.671

Review 7.  Luteolin, a flavonoid with potential for cancer prevention and therapy.

Authors:  Yong Lin; Ranxin Shi; Xia Wang; Han-Ming Shen
Journal:  Curr Cancer Drug Targets       Date:  2008-11       Impact factor: 3.428

8.  Quercetin prevents LPS-induced high-mobility group box 1 release and proinflammatory function.

Authors:  Daolin Tang; Rui Kang; Weimin Xiao; Huali Zhang; Michael T Lotze; Haichao Wang; Xianzhong Xiao
Journal:  Am J Respir Cell Mol Biol       Date:  2009-03-05       Impact factor: 6.914

Review 9.  Bioactive food components, inflammatory targets, and cancer prevention.

Authors:  Young S Kim; Matthew R Young; Gerd Bobe; Nancy H Colburn; John A Milner
Journal:  Cancer Prev Res (Phila)       Date:  2009-03-03

10.  Immunomodulatory responses of peripheral blood mononuclear cells from multiple sclerosis patients upon in vitro incubation with the flavonoid luteolin: additive effects of IFN-beta.

Authors:  Zohara Sternberg; Kailash Chadha; Alicia Lieberman; Allison Drake; David Hojnacki; Bianca Weinstock-Guttman; Frederick Munschauer
Journal:  J Neuroinflammation       Date:  2009-10-13       Impact factor: 8.322

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.